umifenovir has been researched along with Coronavirus Infections in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 41 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Chen, X; Lu, Y; Wang, Z; Zhang, W | 1 |
Dong, L; Gao, J; Hu, S | 1 |
Wang, Y; Zhu, LQ | 1 |
Deng, L; Hong, Z; Li, C; Li, X; Liu, X; Xia, J; Zeng, Q; Zhang, H | 1 |
Duan, Y; Zhou, C; Zhu, HL | 1 |
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM | 1 |
Chen, C; Lu, J; Lu, Z; Xu, T; Xue, Y; Yang, G; Zha, T; Zhu, Z | 1 |
Costanzo, M; De Giglio, MAR; Roviello, GN | 1 |
Ahsan, W; Alhazmi, HA; Bratty, MA; Javed, S; Najmi, A | 1 |
Li, J; Liu, B; Song, D; Zhang, L | 1 |
Huang, J; Lian, N; Lin, Q; Lin, S; Xie, H; Zhao, J | 1 |
Vankadari, N | 1 |
Jiang, J; Lin, S; Ruan, J; Wang, L; Xu, X; Ye, H | 1 |
Chen, C; Chen, M; Cheng, C; Chi, Y; Hu, Z; Huang, S; Jiao, D; Liang, C; Liu, Y; Lv, Y; Sun, W; Wei, H; Yi, Y; Zhang, X | 1 |
Chang, J; Hu, B; Li, YN; Mao, L; Miao, XP; Peng, B; Peng, W; Wan, Y; Wang, WJ; Wang, YL; Zhang, JN; Zhang, YS; Zhou, YF | 1 |
Chen, K; Couban, RJ; Du, X; Gong, X; Guyatt, G; He, N; Ibrahim, QI; Li, X; Li, Y; Liu, F; Liu, J; Liu, W; Shen, N; Tang, Q; Wu, Z; Xu, X; Ye, Z; Ying, Y; Zhai, S; Zhang, Q; Zhang, Y; Zhou, P | 1 |
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A | 1 |
Chen, D; Dong, L; Pan, X; Peng, C; Yang, L | 1 |
Cai, C; Deng, Y; Hu, ZY; Huang, K; Huang, Y; Wang, X; Wang, Y; Xie, J; Xie, Y; Xu, D; Zang, J; Zhan, T; Zheng, F | 1 |
Chen, V; Fish, EN; Kollmann, TR; Shannon, CP; Tebbutt, SJ; Wang, X; Wang, ZH; Wei, XS; Xiang, X; Zhou, Q | 1 |
Li, C; Ren, L; Wang, L | 1 |
Cleland, E; Giovane, RA; Henderson, CE; Rezai, S | 1 |
Zhao, J; Zhou, J; Zhou, X | 1 |
Cai, J; Lang, G; Ni, Q; Shen, X; Sheng, J; Su, J; Wu, W; Xu, K; Zhao, H; Zhu, B | 1 |
Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A | 1 |
Li, Z; Liu, Y; Wang, D | 1 |
Cui, M; Guo, Y; Hong, P; Hou, Z; Liu, F; Lu, Y; Qian, X; Qiu, F; Song, P; Tong, G; Wan, D; Wang, N; Wang, S; Wang, X; Xu, Y; Yu, H; Zhan, Y; Zheng, Z; Zhu, L; Zou, X | 1 |
Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E | 1 |
Chen, C; Chen, Y; Hu, F; Liu, J; Song, J; Song, Y; Tang, X; Ye, M; Yin, G; Zhang, Y | 1 |
Cheng, X; Guan, X; Jin, L; Liang, L; Liao, X; Liu, Y; Shi, Y; Song, L; Su, R; Wang, J; Xin, S; Xing, L; Xu, X; Yang, F; Yu, R; Yu, Y; Zhang, D; Zhou, W; Zhu, B | 1 |
Al-Yamani, MJ; Asdaq, SMB; Jomah, S | 1 |
Ijaz, M; Khan, M; Kharaba, ZJ; Murtaza, G; Shamim, S | 1 |
Bao, S; Deng, Z; Sun, G; Wang, X; Xie, P; Zhao, M; Zhou, Y | 1 |
Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J | 1 |
Choudhary, S; Silakari, O | 1 |
Guo, F; Li, S; Liu, C; Shang, D; Taleb, SJ; Tong, M | 1 |
Luo, S; Tian, M; Wang, L; Xia, W; Zeng, Y; Zha, Y; Zhang, K; Zhang, X | 1 |
Aktas, A; Ataseven, H; Sayin, K; Taskin, AH; Tuzun, B | 1 |
Chen, R; Chen, S; Gao, W; Guo, Q; He, Y; Hua, J; Jin, L; Li, Q; Lu, J; Wang, F; Wang, K; Wang, S; Wu, X; Yan, Q | 1 |
Mishra, SK; Tripathi, T | 1 |
Bulgakova, VA; Leneva, IA; Pshenichnaya, NY | 1 |
16 review(s) available for umifenovir and Coronavirus Infections
Article | Year |
---|---|
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.
Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome | 2020 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment | 2020 |
Treatment of SARS-CoV-2: How far have we reached?
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferon-alpha; Interferon-beta; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.
Topics: Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Medicine; Humans; Hydroxychloroquine; Indoles; Influenza, Human; Lopinavir; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2 | 2020 |
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome | 2020 |
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Interferons; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis | 2020 |
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Teicoplanin | 2020 |
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Drug Repositioning; Esters; Gabexate; Gene Expression Regulation; Guanidines; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antimalarials; Antiviral Agents; Betacoronavirus; Biomedical Research; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Drug Development; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2 | 2020 |
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index | 2020 |
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
Potential strategies for combating COVID-19.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Indoles; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Severity of Illness Index; Viral Vaccines | 2020 |
A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019.
Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Indoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Traditional Chinese Medicine as Potential Therapy for COVID-19.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Janus Kinase Inhibitors; Lopinavir; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
One year update on the COVID-19 pandemic: Where are we now?
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses | 2021 |
[Umifenovir and coronavirus infections: a review of research results and clinical practice].
Topics: Animals; Antiviral Agents; Coronavirus Infections; COVID-19; Humans; Indoles; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |
1 trial(s) available for umifenovir and Coronavirus Infections
Article | Year |
---|---|
Interferon-α2b Treatment for COVID-19.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; China; Cohort Studies; Comorbidity; Coronavirus Infections; COVID-19; Cytokines; Drug Therapy, Combination; Female; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pandemics; Pneumonia, Viral; Sex Factors | 2020 |
24 other study(ies) available for umifenovir and Coronavirus Infections
Article | Year |
---|---|
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
Topics: Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Young Adult | 2020 |
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Studies as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Indoles; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleotides; SARS-CoV-2; Virus Replication | 2020 |
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.
Topics: Administration, Oral; Adult; Antiviral Agents; Cohort Studies; Coronavirus Infections; COVID-19; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; Tomography, X-Ray Computed | 2020 |
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Viral Load | 2020 |
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
Case Report: Viral Shedding for 60 Days in a Woman with COVID-19.
Topics: Acids, Carbocyclic; Aged; Betacoronavirus; China; Coronavirus Infections; COVID-19; Cyclopentanes; Extracorporeal Membrane Oxygenation; Female; Guanidines; Humans; Indoles; Lung; Moxifloxacin; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Virus Shedding | 2020 |
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
Topics: Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Length of Stay; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome | 2020 |
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.
Topics: Antiviral Agents; Betacoronavirus; Biopolymers; Coronavirus Infections; COVID-19; Humans; Indoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |
Quadruple therapy for asymptomatic COVID-19 infection patients.
Topics: Asymptomatic Infections; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
Topics: Adolescent; Adult; Antiviral Agents; Betacoronavirus; China; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Female; Humans; Indoles; Male; Methylprednisolone; Olfaction Disorders; Pandemics; Pneumonia, Viral; SARS-CoV-2; Taste Disorders; Treatment Outcome; Vitamin B 12 | 2020 |
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission: A Preliminary Report of a Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Family; Female; Health Personnel; Humans; Indoles; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pandemics; Pneumonia, Viral; Post-Exposure Prophylaxis; Regression Analysis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Treatment strategies of hospitalized patients with coronavirus disease-19.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Female; gamma-Globulins; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Indoles; Interferons; Lopinavir; Male; Middle Aged; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2 | 2020 |
Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report.
Topics: Adult; Antibody Formation; Antiviral Agents; B-Lymphocytes; Betacoronavirus; Coronavirus Infections; COVID-19; Hospitals; Humans; Immunity, Humoral; Indoles; Male; Nucleotidyltransferases; Pandemics; Patient Discharge; Pneumonia, Viral; Recurrence; SARS-CoV-2; Ventilators, Mechanical | 2020 |
Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Indoles; Interferon-alpha; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Ritonavir; SARS-CoV-2; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells | 2020 |
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Betacoronavirus; Child; China; Cohort Studies; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospital Mortality; Host Microbial Interactions; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Length of Stay; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome; Young Adult | 2020 |
Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Immunoglobulins; Indoles; Interferons; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Factors; SARS-CoV-2; Time Factors; Virus Shedding | 2020 |
Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hospitalization; Humans; Indoles; Interferons; Length of Stay; Lopinavir; Male; Middle Aged; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2020 |
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
Topics: Algorithms; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Biological Availability; Coronavirus Infections; COVID-19; Drug Design; Humans; Indoles; Molecular Docking Simulation; Molecular Structure; Pandemics; Peptide Hydrolases; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Protein Domains; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Virus Attachment; Virus Internalization; Virus Replication | 2020 |
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Indoles; Lopinavir; Medicine, Chinese Traditional; Methylprednisolone; Middle Aged; Moxifloxacin; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Qi; Ritonavir; SARS-CoV-2 | 2020 |
How do arbidol and its analogs inhibit the SARS-CoV-2?
Topics: Betacoronavirus; Binding Sites; Coronavirus Infections; COVID-19; Humans; Indoles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |
Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID-19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series.
Topics: Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Indoles; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2 | 2020 |